Speaker illustration

Doctor Sven Van Laer

Kasterlee (Belgium)

Member of:

European Society of Cardiology

Mitral regurgitation attenuates thrombotic risk in nonrheumatic atrial fibrillation: a new CHA2DS2-VASc score risk modifier?

Event: EHRA 2021

Topic: Stroke Prevention

Session: Stroke prevention with and without LAAO

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb